- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
- Walgreens partners with United Nations Foundation's Shot@Life campaign
- Boots' No7 Men skin care collection comes to Walgreens, Duane Reade
- Walgreens makes flu shots available for 2013-2014 season
DEERFIELD, Ill. — Walgreens on Thursday posted January sales of $5.9 billion, representing an increase of 11.3% from last year. Early morning trading of Walgreens stock was up 51 cents to $42.48.
Only 2.8 percentage points of that increase can be attributed to the acquisition of Duane Reade, the Deerfield, Ill.-based retailer stated. Total front-end sales increased 11.5% in January, and pharmacy sales increased 10.8%, accounting for 66.1% of total sales for the month.
Sales in comparable stores were up 6.1%, with the effect of calendar day shifts positively impacting total comparable sales by 0.7 percentage points. Comparable-store front-end sales increased 4.5%, and customer traffic in comparable stores increased 2.4%, while basket size increased 2.1%. Same-store pharmacy sales were up 6.9%, negatively impacted by 2.9 percentage points due to generic drug introductions in the last 12 months.
Prescriptions filled at comparable stores increased 6.3% in January, negatively impacted by 1.3 percentage points due to fewer flu shots. Flu shots administered season-to-date at pharmacies and clinics totaled more than 6.3 million.
Duane Reade stores were not included in any comparable-store results.